Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma. - Wikidata - wikimedia - TriplyDB

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

http://www.wikidata.org/entity/Q33403094

about

Postchemotherapy changes in testicular germ cell tumours: biology and morphology.Long-term administration of single-agent carboplatin (AUC 4) for advanced testicular seminoma safely achieved complete response in an 80-year-old man with chronic heart failure: A case report.Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.

P2860

Q38783396-D6F84FF4-B2F6-4C5D-AAE8-FFCDEE20CE4B Q42861576-B1DB716B-9D2C-47E1-A23B-2C98BC9CBDA0 Q51745955-449E2F69-41D0-4BF4-B61B-6FFD7AC9D786

P2860

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

http://www.wikidata.org/entity/Q33403094

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

@ast

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

@en

type

label

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

@ast

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

@en

prefLabel

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

@ast

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

@en

P1433

Q33403094-21838CB9-E707-4AF6-85B0-86581FF99B58

P1476

Q33403094-62FFBB58-C920-4DE6-95B4-62EAE64E6190

P2093

Q33403094-0592AC08-F2C4-4579-9BB1-27B276131FE3

Q33403094-071386D3-B8C9-49AB-BC59-36A47FA613A3

Q33403094-13F2A296-9676-4051-9A6C-84D800900F87

Q33403094-1498031A-4522-4DCC-BC41-912EADED8D23

Q33403094-16DEEBDF-5925-4DC2-99E1-D2E876593C59

Q33403094-35C847C2-5CC9-4111-9882-121E27586B6F

Q33403094-38D721C6-1AB6-4855-A10C-47C7040A4C3D

Q33403094-51AA9CEA-12E9-4409-85F2-3335CD713AE5

Q33403094-52B9D8CD-1AA1-444A-AD43-BCD01AD4744B

Q33403094-6AF9E66D-3131-45BC-AD47-BB60E9EC41FD

P2860

Q33403094-1EB034EA-D3E5-45E8-9D53-0A6EAF91ABDF

Q33403094-236C0E90-D3E6-4039-A117-BD37145A2432

Q33403094-2409D2B9-A791-42A0-A08E-A62B63DFA5CB

Q33403094-2451ECCA-3482-4FB7-B2B8-F03929CA7F4A

Q33403094-30D54016-1536-4C3A-B873-B70ABF0B3E93

Q33403094-724B79E4-26B6-42E3-8CC2-BBB769EF1765

Q33403094-833D2E4E-26DE-4326-A73D-84100E2481F4

Q33403094-971ECE33-6F8C-4157-B633-92ECE303034E

Q33403094-D5A78682-BB1D-40F4-B51F-9DA6B96A67FF

Q33403094-E136E4D3-1FB1-469F-91B6-00C8987A2BF5

P304

Q33403094-6F841F60-74CB-4C84-9A9E-975ADF89421F

P31

Q33403094-6E8271D8-C262-4358-8B26-89B9B9B927CB

P356

Q33403094-32AD3BB3-E000-475D-832A-F39F16926D81

P433

Q33403094-E3E68CEB-6AB5-4317-B1E1-EBFDA2DFD097

P478

Q33403094-905A9A6D-33DE-4351-B6C3-FEE6A40A2231

P577

Q33403094-70C7FFD5-A06A-4122-BAA7-88A27B360C96

P698

Q33403094-3CEB029A-E080-4E51-8F03-0E01962B1EF2

P356

0284186X.2012.714078

P1433

Acta Oncologica

P1476

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

@en

P2093

Athena Matakidou

http://www.w3.org/2001/XMLSchema#string

Jonathan Shamash

http://www.w3.org/2001/XMLSchema#string

Laura Tookman

http://www.w3.org/2001/XMLSchema#string

Mariam Jamal-Hanjani

http://www.w3.org/2001/XMLSchema#string

Melissa Phillips

http://www.w3.org/2001/XMLSchema#string

Naveed Sarwar

http://www.w3.org/2001/XMLSchema#string

Peter Wilson

http://www.w3.org/2001/XMLSchema#string

Simon Chowdhury

http://www.w3.org/2001/XMLSchema#string

Stephen Harland

http://www.w3.org/2001/XMLSchema#string

Sukaina Rashid

http://www.w3.org/2001/XMLSchema#string

P2860

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.

Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.

Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations.

Treatment of testicular cancer: a new and improved model.

National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008

Noncancer causes of death in survivors of testicular cancer.

Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.

Possible new approaches to the management of seminoma of the testis.

Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.

Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20

P304

987-993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0284186X.2012.714078

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22943385

http://www.w3.org/2001/XMLSchema#string